Altaris Capital Partners is a healthcare-focused investment firm dedicated to building market-leading companies that enhance the healthcare system through innovation and efficiency. Founded in 2003 and headquartered in New York City, the firm manages approximately $10 billion in assets, with a portfolio of companies that deliver improved access and outcomes for patients. Altaris emphasizes responsible investment practices, including ESG considerations, and actively engages in growth strategies through acquisitions and partnerships.
Recent Transactions involving Altaris Capital Partners
| Deal | Target | Platform | Buyer | Industry |
|---|---|---|---|---|
Altaris to Acquire Minaris Regenerative Medicine from Resonac |
Minaris Regenerative Medicine |
Altaris Capital Partners |
Biotechnology | |
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →